Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors

Johanne Dam Lyhne, Allan ' Ben' Smith, Lisbeth Frostholm, Per Fink, Lars Henrik Jensen, Johanne Dam Lyhne, Allan ' Ben' Smith, Lisbeth Frostholm, Per Fink, Lars Henrik Jensen

Abstract

Background: Cognitive therapy has been shown to reduce fear of cancer recurrence (FCR), mainly in breast cancer survivors. The accessibility of cognitive behavioural interventions could be further improved by Internet delivery, but self-guided interventions have shown limited efficacy. The aim of this study is to test the efficacy of a therapist guided internet-delivered intervention (TG-iConquerFear) vs. augmented treatment as usual (aTAU) in Danish colorectal cancer survivors.

Methods/design: A population-based randomized controlled trial (RCT) comparing TG-iConquerFear with aTAU (1:1) in n = 246 colorectal cancer survivors who suffer from clinically significant FCR (Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) ≥ 22 and semi-structured interview). Evaluation will be conducted at 2 weeks, 3 and 6 months post-treatment and between-group differences will be evaluated. Long-term effects will be evaluated after one year. Primary outcome will be post-treatment FCR (FCRI-SF). Secondary outcomes are global overall health and global quality of life (Visual Analogue Scales 0-100), bodily distress syndrome (BDS checklist), health anxiety (Whiteley-6), anxiety (SCL4-anx), depression (SCL6-dep) and sickness absence and health expenditure (register data). Explanatory outcomes include: Uncertainty in illness (Mishels uncertainty of illness scale, short form, MUIS), metacognitions (MCQ-30 negative beliefs about worry subscale), and perceived risk of cancer recurrence (Visual analogue Scale 1-100).

Discussion: This RCT will provide valuable information on the clinical and cost-effectiveness of TG-iConquerFear vs. aTAU for CRC survivors with clinical FCR, as well as explanatory variables that may act as outcome moderators or mediators.

Trial registration: ClinicalTrials.gov; NCT04287218, registered 25.02.2020. https://ichgcp.net/clinical-trials-registry/NCT04287218&cntry=&state=&city=&dist=.

Keywords: Anxiety; Cognitive therapy; Colorectal cancer; Digital health; Fear of cancer recurrence; Internet-based; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study Timeline

References

    1. Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, et al. Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. (1433–7339 (Electronic)). eng.
    1. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Survivorship. 2013;7(3):300–322. doi: 10.1007/s11764-013-0272-z.
    1. Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Supportive Care Cancer. 2016;24(8):3265–3268. doi: 10.1007/s00520-016-3272-5.
    1. van de Wal M, van de Poll-Franse L, Prins J, Gielissen M. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. (1099–1611 (Electronic)). eng.
    1. Koch L, Jansen L Fau-Brenner H, Brenner H Fau-Arndt V, Arndt V. Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors--a systematic review of quantitative studies. (1099–1611 (Electronic)). eng.
    1. McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol. 2016;35(1):1–9. doi: 10.1037/hea0000238.
    1. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–320. doi: 10.1002/pon.955.
    1. Smith A, Sharpe L, Thewes B, Turner J, Gilchrist J, Fardell JE, et al. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study. Support Care Cancer. 2018;26(12):4207–4216. doi: 10.1007/s00520-018-4294-y.
    1. Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, et al. Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psychooncology. 2020;29(2):430–436. doi: 10.1002/pon.5283.
    1. Waters EA, Arora Nk Fau-Klein WMP, Klein Wm Fau-Han PKJ, Han PK. Perceived risk, trust and health-related quality of life among cancer survivors. (1532–4796 (Electronic)). eng.
    1. Mullens AB, McCaul Kd Fau-Erickson SC, Erickson Sc Fau-Sandgren AK, Sandgren AK. Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors. (1057–9249 (Print)). eng.
    1. Steele N, Haigh R Fau-Knowles G, Knowles G Fau-Mackean M, Mackean M. Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think? (1469–0756 (Electronic)). eng.
    1. Fisher A, Beeken RJ, Heinrich M, Williams K, Wardle J. Health behaviours and fear of cancer recurrence in 10 969 colorectal cancer (CRC) patients. Psychooncology. 2016;25(12):1434–1440. doi: 10.1002/pon.4076.
    1. Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, et al. Exploring the screening capacity of the fear of Cancer recurrence inventory-Short form for clinical levels of fear of cancer recurrence. Psycho-oncology. 2018;27(2):492–499. doi: 10.1002/pon.4516.
    1. Simard S, Savard J. Fear of Cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–251. doi: 10.1007/s00520-008-0444-y.
    1. Hovdenak Jakobsen I, Jeppesen MM, Simard S, Thaysen HV, Laurberg S, Juul T. Initial validation of the Danish version of the fear of Cancer recurrence inventory (FCRI) in colorectal cancer patients. J Cancer Surviv. 2018;12(6):723–732. doi: 10.1007/s11764-018-0709-5.
    1. Custers JAE, Gielissen MFM, Janssen SHV, de Wilt JHW, Prins JB. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. 2016;24(2):555–562. doi: 10.1007/s00520-015-2808-4.
    1. Glaser AW, Fraser Lk Fau-Corner J, Corner J Fau-Feltbower R, Feltbower R Fau-Morris EJA, Morris Ej Fau-Hartwell G, Hartwell G Fau-Richards M, et al. Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. LID - 10.1136/bmjopen-2012-002317 [doi] LID - e002317 [pii]. (2044–6055 (Print)). eng.
    1. Downing A, Morris EJ, Richards M, Corner J, Wright P, Sebag-Montefiore D, et al. Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis. (1527–7755 (Electronic)). eng.
    1. Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology. 2017;26(10):1444–1454. doi: 10.1002/pon.4168.
    1. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68(5):415–426. doi: 10.1016/j.jpsychores.2010.02.004.
    1. Tyrer P, Eilenberg T, Fink P, Hedman E, Tyrer H. Health anxiety: the silent, disabling epidemic. BMJ (Clinical research ed) 2016;353:i2250.
    1. Fink P, Ornbol E, Toft T, Sparle KC, Frostholm L, Olesen F. A new, empirically established hypochondriasis diagnosis. Am J Psychiatry. 2004;161(9):1680–1691. doi: 10.1176/appi.ajp.161.9.1680.
    1. Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psychooncology. 2013;22(12):2797–2806. doi: 10.1002/pon.3348.
    1. Chambers SK, Baade P, Meng X, Youl P, Aitken J, Dunn J. Survivor identity after colorectal cancer: antecedents, prevalence and outcomes. Psychooncology. 2012;21(9):962–969. doi: 10.1002/pon.1991.
    1. Dunn J, Ng SK, Holland J, Aitken J, Youl P, Baade PD, et al. Trajectories of psychological distress after colorectal cancer. Psychooncology. 2013;22(8):1759–1765. doi: 10.1002/pon.3210.
    1. Lebel S, Maheu C, Tomei C, Bernstein LJ, Courbasson C, Ferguson S, et al. Towards the validation of a new, blended theoretical model of fear of cancer recurrence. Psychooncology. 2018;27(11):2594–2601. doi: 10.1002/pon.4880.
    1. Eilenberg T, Kronstrand L, Fink P, Frostholm L. Acceptance and commitment group therapy for health anxiety--results from a pilot study. Journal of anxiety disorders. 2013;27(5):461–468. doi: 10.1016/j.janxdis.2013.06.001.
    1. Kotronoulas G, Papadopoulou C, Burns-Cunningham K, Simpson M, Maguire R. A systematic review of the supportive care needs of people living with and beyond cancer of the colon and/or rectum. Eur J Oncol Nurs. 2017;29:60–70. doi: 10.1016/j.ejon.2017.05.004.
    1. Tauber NM, O'Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of Cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899–2915. doi: 10.1200/JCO.19.00572.
    1. Herschbach P, Book K, Dinkel A, Berg P, Waadt S, Duran G, et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Supportive Care Cancer. 2010;18(4):471–479. doi: 10.1007/s00520-009-0696-1.
    1. Maheu C, Lebel S, Courbasson C, Lefebvre M, Singh M, Bernstein LJ, et al. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer. (1471–2407 (Electronic)). eng.
    1. Merckaert I, Lewis F, Delevallez F, Herman S, Caillier M, Delvaux N, et al. Improving anxiety regulation in patients with breast cancer at the beginning of the survivorship period: a randomized clinical trial comparing the benefits of single-component and multiple-component group interventions. (1099–1611 (Electronic)). eng.
    1. Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, et al. Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of Cancer recurrence. J Clin Oncol. 2017;35(36):4066–4077. doi: 10.1200/JCO.2017.73.1257.
    1. Tomei CA-Ohoo, Lebel S, Maheu C, Lefebvre M, Harris C. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study. (1433–7339 (Electronic)). eng.
    1. Davidson J, Malloch M, Humphris GA-Ohoo. A single-session intervention (the Mini-AFTERc) for fear of cancer recurrence: A feasibility study. (1099–1611 (Electronic)). eng.
    1. van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal Cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35(19):2173–2183. doi: 10.1200/JCO.2016.70.5301.
    1. Cruickshank S, Steel E, Fenlon D, Armes J, Scanlon K, Banks E, et al. A feasibility study of the Mini-AFTER telephone intervention for the management of fear of recurrence in breast cancer survivors: a mixed-methods study protocol. (2055–5784 (Print)). eng.
    1. Dieng M, Butow PN, Costa DS, Morton RL, Menzies SW, Mireskandari S, et al. Psychoeducational intervention to reduce fear of Cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. J Clin Oncol. 2016;34(36):4405–4414. doi: 10.1200/JCO.2016.68.2278.
    1. van Helmondt SJ, van der Lee ML, de Vries J. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer. BMC Cancer. 2016;16:527–016–52562-0.
    1. Murphy MJ, Newby JM, Butow P, Kirsten L, Allison K, Loughnan S, et al. iCanADAPT Early protocol: randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors -vs- treatment as usual. (1471–2407 (Electronic)). eng.
    1. Willems RA, Bolman CA, Mesters I, Kanera IM, Beaulen AA, Lechner L. Cancer survivors in the first year after treatment: the prevalence and correlates of unmet needs in different domains. Psychooncology. 2016;25(1):51–57. doi: 10.1002/pon.3870.
    1. Butow P, Williams D, Thewes B, Tesson S, Sharpe L, Smith AB, et al. A psychological intervention (ConquerFear) for treating fear of cancer recurrence: views of study therapists regarding sustainability. Psychooncology. 2019;28(3):533–539. doi: 10.1002/pon.4971.
    1. Smith AB, Bamgboje-Ayodele A, Butow P, Klein B, Turner J, Sharpe L, et al. Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear) Psychooncology. 2020;29(1):98–106. doi: 10.1002/pon.5218.
    1. Leykin Y, Thekdi SM, Shumay DM, Munoz RF, Riba M, Dunn LB. Internet interventions for improving psychological well-being in psycho-oncology: review and recommendations. Psychooncology. 2012;21(9):1016–1025. doi: 10.1002/pon.1993.
    1. van Helmondt SJ, van der Lee ML, van Woezik RAM, Lodder P, de Vries J. No effect of CBT-based online self-help training to reduce fear of cancer recurrence: first results of the CAREST multicenter randomized controlled trial. Psychooncology. 2020;29(1):86–97. doi: 10.1002/pon.5233.
    1. Compen F, Bisseling E, Schellekens M, Donders R, Carlson L, van der Lee M, et al. Face-to-face and internet-based mindfulness-based cognitive therapy compared with treatment as usual in reducing psychological distress in patients with Cancer: a multicenter randomized controlled trial. J Clin Oncol. 2018;36(23):2413–2421. doi: 10.1200/JCO.2017.76.5669.
    1. Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med. 2007;37(3):319–328. doi: 10.1017/S0033291706008944.
    1. Pihlaja S, Stenberg JH, Joutsenniemi K, Mehik H, Ritola V, Joffe G. Therapeutic alliance in guided internet therapy programs for depression and anxiety disorders - a systematic review. Internet Interv. 2018;11:1–10. doi: 10.1016/j.invent.2017.11.005.
    1. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. doi: 10.1097/00007632-200012150-00014.
    1. McMullen C, Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, et al. Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey. Support Care Cancer. 2019;27(1):147–156. doi: 10.1007/s00520-018-4299-6.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Clinical research ed) 2013;346:e7586.
    1. Nienhuis FJ, van de Willige G, Rijnders CA, de Jonge P, Wiersma D. Validity of a short clinical interview for psychiatric diagnosis: the mini-SCAN. Br J Psychiatry. 2010;196(1):64–68. doi: 10.1192/bjp.bp.109.066563.
    1. Petersen MW, Schroder A, Jorgensen T, Ornbol E, Dantoft TM, Eliasen M, et al. RIFD - a brief clinical research interview for functional somatic disorders and health anxiety. J Psychosom Res. 2019;122:104–111. doi: 10.1016/j.jpsychores.2019.04.001.
    1. Short CE, DeSmet A, Woods C, Williams SL, Maher C, Middelweerd A, et al. Measuring engagement in eHealth and mHealth behavior change interventions: viewpoint of methodologies. J Med Internet Res. 2018;20(11):e292. doi: 10.2196/jmir.9397.
    1. Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, et al. Empirical validation of the English version of the fear of Cancer recurrence inventory. Quality Life Res. 2016;25(2):311–321. doi: 10.1007/s11136-015-1088-2.
    1. Costa DSJ. Screening for clinical levels of fear of cancer recurrence. Psychooncology. 2017.
    1. Costa DSJ, Smith AB, Fardell JE. The sum of all fears: conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer. 2016;24(1):1–3. doi: 10.1007/s00520-015-2943-y.
    1. Budtz-Lilly A, Fink P, Ornbol E, Vestergaard M, Moth G, Christensen KS, et al. A new questionnaire to identify bodily distress in primary care: the 'BDS checklist'. J Psychosom Res. 2015;78(6):536–545. doi: 10.1016/j.jpsychores.2015.03.006.
    1. Parloff MB, Kelman HC, Frank JD. Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy. Am J Psychiatry. 1954;111(5):343–352. doi: 10.1176/ajp.111.5.343.
    1. Fink P, Ewald H, Jensen J, Sorensen L, Engberg M, Holm M, et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res. 1999;46(3):261–273. doi: 10.1016/S0022-3999(98)00092-0.
    1. Veddegjaerde KE, Sivertsen B, Wilhelmsen I, Skogen JC. Confirmatory factor analysis and item response theory analysis of the Whiteley index. Results from a large population based study in Norway. The Hordaland health study (HUSK) J Psychosom Res. 2014;77(3):213–218. doi: 10.1016/j.jpsychores.2014.06.011.
    1. Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30(5):258–263. doi: 10.1097/00006199-198109000-00002.
    1. Hagen KB, Aas T, Lode K, Gjerde J, Lien E, Kvaloy JT, et al. Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel uncertainty in illness scale. Eur J Oncol Nurs. 2015;19(2):113–119. doi: 10.1016/j.ejon.2014.10.009.
    1. Wells A, Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther. 2004;42(4):385–396. doi: 10.1016/S0005-7967(03)00147-5.
    1. Cartwright-Hatton S, Wells A. Beliefs about worry and intrusions: the meta-cognitions questionnaire and its correlates. J Anxiety Disorders. 1997;11(3):279–296. doi: 10.1016/S0887-6185(97)00011-X.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi